Omega Diagnostics Group PLC Notice of Results (0108C)
June 16 2021 - 1:00AM
UK Regulatory
TIDMODX
RNS Number : 0108C
Omega Diagnostics Group PLC
16 June 2021
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Notice of results
Investor presentation
Omega (AIM: ODX), the medical diagnostics company focused on
CD4, infectious diseases and food intolerance, will issue its
financial results for the year ended 31 March 2021 on Tuesday 13
July 2021.
Investor meeting
Colin King and Kieron Harbinson will provide a live presentation
relating to the Company's Final Results via the Investor Meet
Company platform on Tuesday 13 July 2021 at 4:30pm BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via your
Investor Meet Company dashboard up until 9am the day before the
meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add
to meet OMEGA DIAGNOSTICS GROUP PLC via:
https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor
Investors who already follow OMEGA DIAGNOSTICS GROUP PLC on the
Investor Meet Company platform will automatically be invited.
Contacts:
Omega Diagnostics Group PLC www.omegadiagnostics.com
Colin King, Chief Executive via Walbrook PR
Kieron Harbinson, Group Finance
Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley (Corporate
Finance)
Alice Lane (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORGZGMVNKMGMZM
(END) Dow Jones Newswires
June 16, 2021 02:00 ET (06:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024